ondasdechoque.org
PT-BR

Rotator-cuff / subacromial pain: mixed or unspecified subtype · Review · 2026

Does adding shockwave after hyaluronic acid injections help shoulder pain?

In one study in this review, people who had focused shockwave straight after hyaluronic acid shoulder injections had better shoulder function at 3 and 6 months than with injections alone. Pain improved in all groups with no clear difference, and by 12 months function no longer clearly differed.

Possible early help with shoulder function
people in the shockwave study
93
focused shockwave sessions
1–2
months of follow-up
12

Good to know: Based on one study of 93 people; one or two shockwave sessions made no clear difference.

Lavigne A, Sandouk E, Hiett A, et al. Shoulder & Elbow, 2026 · Read the paper ↗

How this study worked

One answer
A review gathers earlier studies to answer one question. Illustration, not to scale.

What the trials used

Focused ESWT after HA
Ko et al. compared three weekly landmark-guided subacromial low-molecular-weight HA injections alone with the same three injections followed immediately by one or two focused ESWT sessions. The review does not report ESWT energy, shock count or session interval.

Who took part

93 people with rotator-cuff tendon pain in one study, within a review of 11 hyaluronic acid studies.

Side effects

No one in the shockwave study reported side effects.

All the numbers and the full appraisal
FROM THE FULL PAPER

What the full paper reports.

Narrative review of 11 clinical studies (nine RCTs, two prospective nonrandomized studies) of hyaluronic acid for rotator-cuff tendinopathy. The Ko et al. study enrolled 93 total participants (Table 1 reports “93 (93 HA)”); its three groups were HA alone, HA followed by one focused ESWT session, and HA followed by two sessions. Arm-specific denominators are not stated.

Pain and functional outcomes; numerical scales not reproduced1 reported outcome
01
Follow-up through 12 months; function at months 3 and 6

Pain and function with HA plus focused ESWT

Pain and functional outcomes; numerical scales not reproduced No numerical between-group estimate

All groups improved from baseline through 12 months. Pain improvement did not differ significantly among groups. Function favored both HA+F-ESWT groups over HA alone at 3 and 6 months, but not significantly at 12 months. One versus two F-ESWT sessions did not differ for pain or function.

Analysis details and source

Table 1 reports total study sample N=93 (“93 (93 HA)”), but arm-specific denominators, scale scores, variance and numerical effect estimates are not reported. No participant reported an adverse event.

How treatment was delivered
Focused ESWT after HA

Ko et al. compared three weekly landmark-guided subacromial low-molecular-weight HA injections alone with the same three injections followed immediately by one or two focused ESWT sessions. The review does not report ESWT energy, shock count or session interval.

HARMS & TOLERABILITY

The review says no participant in the Ko study reported an adverse event; no group denominators or broader ESWT safety analysis are provided.

LIMITS OF THE ANALYSIS

Narrative review, not pooled ESWT analysis. The combination result comes from one study without reproduced group sizes or numerical estimates. No ESWT-only arm was reported, so its effect cannot be separated from HA. Protocol details are incomplete.

Findings checked against the full source by a separate automated reviewer.

Limitations noted by the reviewers

  • Narrative review, not pooled ESWT analysis. The combination result comes from one study without reproduced group sizes or numerical estimates. No ESWT-only arm was reported, so its effect cannot be separated from HA. Protocol details are incomplete.
Research review

Source-linked critical reading

Scoping / narrative review

Reading depthMaterial consulted
Technical source record

Read complete article, its single table, Ko focused ESWT study description, injection characteristics, harms, discussion and conclusion.

Review statusAI-assisted draft · independent automated checkThis automated check comes before the editor’s clinical review.
Design and evidence base

Narrative review of studies searched through September 2024, including nine RCTs and two prospective nonrandomized studies.

Participants

The review covers rotator cuff tendinopathy; one included study by Ko et al. compared HA with focused ESWT added. Table 1 reports a total of 93 participants in Ko et al. (“93 (93 HA)”). The results describe three groups, but do not state arm-specific denominators; no split of the total is inferred.

Intervention

Ko et al. compared three weekly landmark-guided subacromial low-molecular-weight HA injections alone with the same injections followed immediately by one or two focused ESWT sessions. Energy and shock count were not stated.

Comparator

The comparison was HA alone versus HA plus one or two F-ESWT sessions; no ESWT-only arm was described.

Outcomes

The review reports pain and function through 12 months but does not reproduce sample size by arm, scale-specific values or effect estimates.

Comparative findings

Pain did not differ significantly among groups. Function favored HA+F-ESWT at months 3 and 6, but not significantly at 12 months. One versus two sessions did not differ.

Harms

No participant in the Ko study reported an adverse event; broader safety data are not given.

Limitations

One combination study, no reproduced numerical estimates and no ESWT-alone arm limit interpretation.

Applicability

Evidence applies only to focused ESWT after subacromial HA injections and does not establish ESWT monotherapy efficacy.

Research needs

Trials should include HA-only, ESWT-only and combination arms, report device settings and group-level outcomes, and follow harms and outcomes long term.

THE ORIGINAL SOURCE

Read the original article.

Current evidence on hyaluronic acid injections for rotator cuff tendinopathy: A scoping review.

Lavigne A, Sandouk E, Hiett A, Chang MC, Bélanger V, Lamontagne M, Khadavi M. · Shoulder & elbow · 2026

Open the publication record or available full-text files.

Checked against the full paper · Clinical review: Dr. Marcus Yu Bin Pai, · How we review →